Cargando…
Human amniotic mesenchymal stem cells inhibit hepatocellular carcinoma in tumour‐bearing mice
Hepatocellular carcinoma (HCC) is the third leading cause of the cancer‐related death in the world. Human amniotic mesenchymal stem cells (hAMSCs) have been characterized with a pluripotency, low immunogenicity and no tumorigenicity. Especially, the immunosuppressive and anti‐inflammatory effects of...
Autores principales: | Liu, Quan‐Wen, Li, Jing‐Yuan, Zhang, Xiang‐Cheng, Liu, Yu, Liu, Qian‐Yu, Xiao, Ling, Zhang, Wen‐Jie, Wu, Han‐You, Deng, Ke‐Yu, Xin, Hong‐Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521292/ https://www.ncbi.nlm.nih.gov/pubmed/32798252 http://dx.doi.org/10.1111/jcmm.15668 |
Ejemplares similares
-
Human amniotic mesenchymal stem cells and their paracrine factors promote wound healing by inhibiting heat stress-induced skin cell apoptosis and enhancing their proliferation through activating PI3K/AKT signaling pathway
por: Li, Jing-Yuan, et al.
Publicado: (2019) -
Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure
por: Liu, Quan-Wen, et al.
Publicado: (2018) -
Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice
por: Liu, Quan-Wen, et al.
Publicado: (2022) -
Human amniotic mesenchymal stem cells-conditioned medium protects mice from high-fat diet-induced obesity
por: Tan, Hui-Lan, et al.
Publicado: (2021) -
Therapeutic potential of human amniotic membrane-derived mesenchymal stem cells in APP transgenic mice
por: Jiao, Hongliang, et al.
Publicado: (2016)